Global Critical Care Equipment Market is estimated to be US$ 135.94 billion by 2030 with a CAGR of 19.8% during the forecast period.

Global Critical Care Equipment Market accounted for US$ 2.43 billion in 2020 and is estimated to be US$ 5.02 billion by 2030 and is anticipated to register a CAGR of 7.50%. Critical care is specialist treatment for individuals who are facing life-threatening diseases and require round-the-clock monitoring and care. Intensive care equipment is used in intensive care units to give care and monitor the health of patients 24 hours a day, seven days a week. Cardiac support equipment, pain management equipment, emergency resuscitation equipment, life support, patient monitoring equipment, and breathing equipment are all examples of critical care equipment used in intensive care units. For individuals with breathing problems, a ventilator, also known as a respirator, is used to help or control pulmonary ventilation.

The report "Global Critical Care Equipment Market, By Product Type (Beds, Ventilators, Pulse Oximeters, Dialysis Equipment, and Others), By Application (Neurology, Cardiology, Respiratory, Renal, Oncology, Trauma, and Others), and By End User (Hospitals, Ambulatory Surgical Centers, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’

Key Highlights:

  • On April 29, 2020, Medtronic increased output of its high-performance ventilators by about 40%. By releasing its intellectual property and ventilator designs to the public for third-party ventilator production, the company is cooperating with third-parties to investigate additional non-traditional techniques to boost ventilator production.
  • Smiths Medical (US) teamed with HCA Capital Division (US) in April 2019 to link the Medfusion 4000 system with PharmGuard Software with HCA's electronic medical records system to improve patient outcomes by decreasing prescription mistakes (EMR).

Analyst View:

The market's growth is likely to be aided by significant investment in contemporary medical treatments for those with critical healthcare issues. The high cost of intensive care equipment, on the other hand, is expected to limit the worldwide intensive care equipment market's growth over the forecast period. Furthermore, the disruption of supply chain and logistics caused by COVID-19's rapid spread is projected to stymie the growth of the intensive care unit equipment market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Critical Care Equipment Market, By Product Type (Beds, Ventilators, Pulse Oximeters, Dialysis Equipment, and Others), By Application (Neurology, Cardiology, Respiratory, Renal, Oncology, Trauma, and Others), and By End User (Hospitals, Ambulatory Surgical Centers, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Critical-Care-Equipment-Market-4813

Key Market Insights from the report:

Global Critical Care Equipment Market accounted for US$ 2.43 billion in 2020 and is estimated to be US$ 5.02 billion by 2030 and is anticipated to register a CAGR of 7.50%. The Global Critical Care Equipment Market is segmented based on Product, Application, End-User and Region.

  • Based on Product Type, Global Critical Care Equipment Market is segmented into Beds, Ventilators, Pulse Oximeters, Dialysis Equipment, and Others.
  • Based on Application, Global Critical Care Equipment Market is segmented into Neurology, Cardiology, Respiratory, Renal, Oncology, Trauma, and Others.  
  • Based on End-User, Global Critical Care Equipment Market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. 
  • By Region, the Global Critical Care Equipment Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Global Critical Care Equipment Market:

The key players operating in the critical care equipment market are Koninklijke Philips N.V. (Netherlands), General Electric Company (U.S.), Medtronic plc (U.S.), Drägerwerk AG & Co. KGaA (Germany), Skanray Technologies Pvt. Ltd. (India), Maquet Holding B.V. & Co. KG. (Germany), BPL Medical Technologies Ltd (India), B. Braun Melsungen AG (Germany), Akas Medical (India), Smiths Medical (U.S.), Nihon Kohden Corporation (Japan), and Fresenius Kabi (Germany).

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

  • Explains an overview of the product portfolio, including product development, planning, and positioning
  • Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
  • Detailed analysis of the market revenue over the forecasted period.
  • Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
  • Study on the segments that are anticipated to dominate the market.
  • Study on the regional analysis that is expected to register the highest growth over the forecast period

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Comments

Post a Comment

Popular posts from this blog

Global Platelet Rich Plasma Market is estimated to be US$ 1003.06 million by 2030 with a CAGR of 11.50% during the forecast period.

Image
Global Platelet Rich Plasma Market accounted for US$ 337.23 million in 2020 and is estimated to be US$ 1003.06 million by 2030 and is anticipated to register a CAGR of 11.50%. Platelet-rich plasma (PRP), also known as autologous conditioned plasma, is created by extracting red blood cells from blood. When the concentration of platelets in human blood is reduced, platelet-rich plasma is separated, which contains a concentration of platelets above typical values. Platelets thicken the blood and aid in the repair of muscles, ligaments, and tendons. They are extremely high in healing and connective tissue development factors. Platelet-rich plasma (PRP) blends the body's natural ability to heal itself with modern technologies. It has a wide range of medical applications, including neurology, orthopaedics, and ophthalmology. It's also employed in procedures like tendon repair and rotator cuff augmentation. The report   " Global Platelet Rich Plasma Market, By Type (Pure Platelet
Read more

Neurodegenerative Disorder Therapeutics Market - Improvement in the healthcare infrastructure is likely to create new opportunity for the market

Image
Neurodegenerative Disorder Therapeutics Market   accounted for US$ 9.32 billion in 2019 and is estimated to be US$ 21.3 billion by 2029 and is anticipated to register a CAGR of 8.7% The report " Global  Neurodegenerative Disorder Therapeutics Market, By  Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, and Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In November 2019, Alkermes plc and Rodin Therapeutics, Inc. announced that they have entered into a definitive agreement under which Alkermes will acquire Rodin, a privately held biopharmaceutical company focused on developing novel,
Read more

Systemic Lupus Erythematosus Market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%

Image
  Systemic Lupus Erythematosus (SLE) is the chronic, autoimmune disorder which involves several organ-systems such as kidney, heart, blood, skin, joints, and lungs in most severe cases, brain. In this disease, the human immune system converts hyperactive and attacks the healthy, normal tissues of the body. SLE can often result in symptoms such as malar rash, sub-acute cutaneous lesions, discoid lesions, arthritis, photosensitivity, oral ulcers, serositis, nephropathy, thrombocytopenia, haemolytic anemia, neurologic involvement, fever, thrombosis, Raynaud’s phenomenon, livedo reticularis, and myositis. The global systemic lupus erythematosus market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%. The report  " Global   Systemic Lupus Erythematosus Market, By Drug Classes (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, and Biologics), By Route of Administration (Oral, Intravenous, and
Read more